Royal Bank of Canada
CSCI

Royal Bank of Canada’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Royal Bank of Canada’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,239
Closed -$14K – 7619
2025
Q2 		$14K Buy
4,239
+372
+10% +$1.24K ﹤0.01% 6390
2025
Q1 		$11K Sell
3,867
-69
-2% -$203 ﹤0.01% 6135
2024
Q4 		$11K Buy
3,936
+1,409
+56% +$4.59K ﹤0.01% 6336
2024
Q3 		$9K Sell
2,527
-88
-3% -$447 ﹤0.01% 6374
2024
Q2 		$12K Buy
2,615
+2,499
+2,154% +$19.1K ﹤0.01% 6282
2024
Q1 		$1K Sell
116
-49
-30% -$377 ﹤0.01% 6892
2023
Q4 		$1K Sell
165
-666
-80% -$4.92K ﹤0.01% 7007
2023
Q3 		$8K Buy
831
+197
+31% +$2.19K ﹤0.01% 6506
2023
Q2 		$7K Buy
634
+202
+47% +$2.3K ﹤0.01% 6590
2023
Q1 		$5K Buy
432
+288
+200% +$3.83K ﹤0.01% 6587
2022
Q4 		$2K Buy
144
+22
+18% +$326 ﹤0.01% 6958
2022
Q3 		$2K Buy
+122
New +$2.34K ﹤0.01% 7081
2022
Q2 		– Sell
-1
Closed -$25 – 7788
2022
Q1 		$0 Sell
1
-3
-75% -$108 ﹤0.01% 8087
2021
Q4 		$0 Sell
4
-12
-75% -$632 ﹤0.01% 7948
2021
Q3 		$1K Buy
16
+7
+78% +$497 ﹤0.01% 7517
2021
Q2 		$1K Buy
+9
New +$856 ﹤0.01% 7356
2021
Q1 		– Sell
-11
Closed – – 7749
2020
Q4 		$0 Sell
11
-5
-31% -$185 ﹤0.01% 7334
2020
Q3 		$1K Sell
16
-1
-6% -$44 ﹤0.01% 6496
2020
Q2 		$1K Buy
17
+9
+113% +$824 ﹤0.01% 6497
2020
Q1 		$0 Buy
8
+6
+300% +$547 ﹤0.01% 7097
2019
Q4 		$0 Sell
2
-3
-60% -$280 ﹤0.01% 7186
2019
Q3 		$0 Buy
5
+4
+400% +$866 ﹤0.01% 7207
2019
Q2 		$0 Buy
+1
New +$353 ﹤0.01% 7256
2019
Q1 		– Sell
-9
Closed -$3K – 7163
2018
Q4 		$3K Buy
9
+3
+50% +$717 ﹤0.01% 6374
2018
Q3 		$1K Buy
6
+4
+200% +$734 ﹤0.01% 6629
2018
Q2 		$0 Sell
2
-5
-71% -$922 ﹤0.01% 6816
2018
Q1 		$1K Hold
7
– – ﹤0.01% 6235
2017
Q4 		$2K Hold
7
– – ﹤0.01% 6306
2017
Q3 		$1K Buy
7
+6
+600% +$1.1K ﹤0.01% 6641
2017
Q2 		$0 Hold
1
– – ﹤0.01% 6806
2017
Q1 		$0 Buy
+1
New +$294 ﹤0.01% 6856
2016
Q4 		– Hold
0
– – – 6811
2016
Q3 		– Sell
-1
Closed -$350 – 6606
2016
Q2 		$0 Sell
1
-24
-96% -$8.64K ﹤0.01% 6555
2016
Q1 		$8K Buy
25
+1
+4% +$330 ﹤0.01% 5810
2015
Q4 		$11K Buy
24
+14
+140% +$8.79K ﹤0.01% 5941
2015
Q3 		$8K Buy
10
+9
+900% +$13.1K ﹤0.01% 5998
2015
Q2 		$1K Hold
1
– – ﹤0.01% 6475
2015
Q1 		$3K Hold
1
– – ﹤0.01% 5862
2014
Q4 		$4K Hold
1
– – ﹤0.01% 5862
2014
Q3 		$9K Hold
1
– – ﹤0.01% 5515
2014
Q2 		$6K Hold
1
– – ﹤0.01% 5534
2014
Q1 		$6K Hold
1
– – ﹤0.01% 5550
2013
Q4 		$7K Hold
1
– – ﹤0.01% 5540
2013
Q3 		$8K Hold
1
– – ﹤0.01% 5498
2013
Q2 		$9K Buy
+1
New +$19K ﹤0.01% 5315

Other funds holding CSCI

TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Royal Bank of Canada's CSCI Position: Q3 2025 in Review

Royal Bank of Canada sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2025, closing a stake of 4,239 shares — an estimated $14K sold.

Royal Bank of Canada first reported a position in CSCI in Q2 2013 and held it in 44 quarters. The position peaked at $14K in Q2 2025. 2 funds tracked by Wall St. Rank hold CSCI as of Q3 2025.

  • Royal Bank of Canada reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 4,239 COSCIENS Biopharma Inc. Common Stock shares in Q3 2025, an estimated $14K.
  • Royal Bank of Canada first reported a position in COSCIENS Biopharma Inc. Common Stock in Q2 2013 and held it in 44 quarters.
  • Royal Bank of Canada's COSCIENS Biopharma Inc. Common Stock position peaked at $14K in Q2 2025.
  • 2 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2025.

Based on Royal Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.